Ratings by Rodman & Renshaw (Michael G. King, Jr)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2026 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
4.50 (4.92) |
9.33% | Details |
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2026 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
4.50 (4.92) |
9.33% | Details |